Quantcast

Latest pharmaceutical industry Stories

2014-08-18 08:28:18

AMSTERDAM, August 18, 2014 /PRNewswire/ -- Event to facilitate regional growth alongside South Korean government $8.9 billion commitment to drug development by 2020 Leading events organizer UBM Live today announces the opening of CPhI Korea 2014, which will take place on September 2nd-3rd 2014 at the COEX in Seoul, South Korea. Co-organized by the Korean Pharmaceutical Traders Association, the event will co-locate with ICSE, creating a...

2014-08-18 08:28:16

AMSTERDAM, August 18, 2014 /PRNewswire/ -- Leading Global Industry Trends, Lighting up the China Pharmaceutical Dream CPhI & P-MEC China 2014 Event Achieved its Grand Closing CPhI, ICSE & BioPh China 2014 and P-MEC, InnoPack & LABWorld China 2014, held on 26th -28th of June hosted by UBM Live and CCCMHPIE and co-organized by UBM Sinoexpo, achieved its successful close at Shanghai New International Expo Centre. (Logo:...

2014-08-15 12:25:07

ATLANTA, Aug. 15, 2014 /PRNewswire/ -- Avion Pharmaceuticals, LLC, announces the signing of a commercial license agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) for the development and commercialization of four Captisol-enabled programs. Under the terms of the agreement, Ligand is entitled to receive an up-front payment, and is eligible to receive revenue from Captisol® material sales, potential milestone payments, and royalties on future net sales of the products...

2014-08-14 23:11:14

With 15 interactive exercises, this workshop, taught by internationally renowned medical device process validation expert Dan O’Leary, is designed to provide industry best practices to achieve sustainable process validation with regulatory bodies around the world. Attendees will learn the theories of process validation and documentation and how to put them into practice. Falls Church, VA (PRWEB) August 14, 2014 Innovative Process Validation Strategies for Medical Devices: Proving Your...

2014-08-14 16:27:42

Pharmacy benefit manager misleading patients, advocates say FAIRHOPE, Ala., Aug. 14, 2014 /PRNewswire/ -- Express Scripts, the nation's largest pharmacy benefit manager, is offering ambiguous and misleading reasons for ending coverage of customized prescription medications for 540,000 individuals in order to conceal financial motives, a Patients and Physicians for Rx Access said Thursday, Aug. 14. The organization is fighting to stop the unprecedented benefit cuts being made by...

2014-08-14 08:30:05

First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today provided an update on its European Medicines Agency (EMA) post-approval studies for ADASUVE(®) inhalation powder, pre-dispensed (loxapine). As part of the ADASUVE approval process with the EMA, Alexza is required to conduct five post-approval studies: -- a benzodiazepine interaction study - study completed and data...

2014-08-14 08:29:19

SAN DIEGO, Aug. 14, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical development and manufacturing, announced that Mr. John McCarty has joined Formex as Scientific Advisor and Science Advisory Board Member. Mr. McCarty has over 30 years of experience in drug product development within the pharmaceutical and biotechnology industries. Mr. McCarty has broad expertise in the development of all major dosage forms and is an inventor on over 17 U.S. and foreign...

2014-08-14 08:28:23

-- Expanded Data from Phase II MS Trial to be Released Next Month; Plans on Course to Advance C. difficile and C-IBS Programs into the Clinic During 2014 -- ROCKVILLE, Md., Aug. 14, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today reported financial results for the three and six months ended June 30, 2014, and provided an operational...

2014-08-13 23:08:14

The Aug. 8 issue of Atlantic Information Services’s Drug Benefit News (DBN) takes a look at criticism surrounding formulary exclusion lists, which pharmacy benefit managers see as a way to flex their negotiating muscle and control rising drug trend. Washington, DC (PRWEB) August 13, 2014 In a continuing effort to flex their negotiating muscle and control rising drug trend, CVS Caremark Corp. and Express Scripts Holding Co. on Aug. 1 released their respective long-awaited formulary...

2014-08-13 23:03:42

Researchmoz.us announces addition of new report "Neuropathy Global Clinical Trials Review, H2, 2014" to its database. Albany, NY (PRWEB) August 13, 2014 "Clinical trial report, Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'